AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates ...
Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...
Zacks.com on MSN5dOpinion
5 Large Drug Stocks to Keep An Eye On in the New YearThe drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback